Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prisoners | 3 | 2024 | 314 | 1.560 |
Why?
|
Specialties, Surgical | 2 | 2024 | 389 | 1.230 |
Why?
|
Immunotherapy | 6 | 2024 | 4642 | 1.190 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2024 | 1084 | 1.020 |
Why?
|
Internship and Residency | 5 | 2024 | 5879 | 0.880 |
Why?
|
Antigens, Surface | 9 | 2005 | 1607 | 0.840 |
Why?
|
Immunoglobulin Class Switching | 1 | 2024 | 289 | 0.810 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2024 | 147 | 0.800 |
Why?
|
General Surgery | 2 | 2024 | 1692 | 0.770 |
Why?
|
Students, Medical | 3 | 2023 | 1938 | 0.720 |
Why?
|
Plasma Cells | 1 | 2024 | 597 | 0.720 |
Why?
|
Cyclonic Storms | 1 | 2021 | 116 | 0.690 |
Why?
|
Carcinoma, Lobular | 1 | 2024 | 480 | 0.680 |
Why?
|
Cultural Diversity | 1 | 2023 | 369 | 0.680 |
Why?
|
Job Description | 1 | 2019 | 59 | 0.670 |
Why?
|
Interleukins | 1 | 2024 | 782 | 0.650 |
Why?
|
Terrorism | 1 | 2021 | 210 | 0.600 |
Why?
|
Immunoglobulin E | 1 | 2024 | 1505 | 0.590 |
Why?
|
Faculty, Medical | 2 | 2023 | 1205 | 0.590 |
Why?
|
Leadership | 2 | 2023 | 1386 | 0.570 |
Why?
|
Clinical Clerkship | 1 | 2023 | 564 | 0.560 |
Why?
|
Interviews as Topic | 1 | 2024 | 2696 | 0.560 |
Why?
|
Physicians, Women | 1 | 2023 | 510 | 0.560 |
Why?
|
Mentors | 1 | 2022 | 663 | 0.540 |
Why?
|
Emigrants and Immigrants | 1 | 2023 | 544 | 0.530 |
Why?
|
Breast Neoplasms | 5 | 2024 | 20981 | 0.530 |
Why?
|
Disaster Planning | 1 | 2021 | 557 | 0.510 |
Why?
|
Disasters | 1 | 2021 | 520 | 0.510 |
Why?
|
Terminology as Topic | 2 | 2020 | 1528 | 0.500 |
Why?
|
Semantics | 1 | 2019 | 612 | 0.500 |
Why?
|
Radiology, Interventional | 1 | 2019 | 477 | 0.490 |
Why?
|
Laparoscopy | 2 | 2024 | 2030 | 0.490 |
Why?
|
Neoplasms | 6 | 2024 | 22125 | 0.480 |
Why?
|
Tissue and Organ Procurement | 1 | 2023 | 962 | 0.470 |
Why?
|
Specialization | 1 | 2019 | 778 | 0.470 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2293 | 0.460 |
Why?
|
Organ Transplantation | 1 | 2024 | 1164 | 0.460 |
Why?
|
Education, Medical, Undergraduate | 1 | 2023 | 1071 | 0.450 |
Why?
|
Sarcoma | 1 | 2024 | 1800 | 0.420 |
Why?
|
Career Choice | 3 | 2024 | 757 | 0.420 |
Why?
|
Medicine | 1 | 2020 | 942 | 0.400 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4538 | 0.400 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4308 | 0.390 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 151 | 0.370 |
Why?
|
Sirtuin 1 | 1 | 2011 | 246 | 0.340 |
Why?
|
United States | 14 | 2024 | 72337 | 0.330 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2011 | 4574 | 0.320 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2813 | 0.300 |
Why?
|
Humans | 47 | 2024 | 761098 | 0.300 |
Why?
|
Immunologic Factors | 1 | 2017 | 1589 | 0.290 |
Why?
|
Southeastern United States | 2 | 2024 | 91 | 0.290 |
Why?
|
Cell Differentiation | 3 | 2024 | 11505 | 0.280 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7400 | 0.280 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1168 | 0.270 |
Why?
|
Interleukin-18 | 1 | 2008 | 250 | 0.270 |
Why?
|
Blood Proteins | 5 | 2004 | 1172 | 0.260 |
Why?
|
Schools, Medical | 2 | 2022 | 877 | 0.240 |
Why?
|
Interferon-gamma | 5 | 2008 | 3155 | 0.240 |
Why?
|
Mastectomy, Modified Radical | 1 | 2024 | 62 | 0.230 |
Why?
|
Prisons | 2 | 2023 | 174 | 0.230 |
Why?
|
Apoptosis Regulatory Proteins | 9 | 2005 | 1138 | 0.230 |
Why?
|
Receptors, Lysophosphatidic Acid | 2 | 2014 | 77 | 0.220 |
Why?
|
School Admission Criteria | 1 | 2024 | 107 | 0.220 |
Why?
|
Texas | 1 | 2024 | 403 | 0.220 |
Why?
|
Personnel Selection | 1 | 2024 | 196 | 0.210 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5318 | 0.200 |
Why?
|
T-Lymphocytes | 7 | 2019 | 10203 | 0.200 |
Why?
|
Peptides | 7 | 2008 | 4353 | 0.200 |
Why?
|
Genetic Loci | 1 | 2011 | 2623 | 0.200 |
Why?
|
Palatine Tonsil | 1 | 2002 | 193 | 0.200 |
Why?
|
Police | 2 | 2022 | 157 | 0.200 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26068 | 0.190 |
Why?
|
Immunologic Memory | 1 | 2008 | 1361 | 0.190 |
Why?
|
Melanoma, Experimental | 1 | 2004 | 561 | 0.190 |
Why?
|
Retrospective Studies | 8 | 2024 | 80673 | 0.190 |
Why?
|
Pandemics | 4 | 2022 | 8663 | 0.180 |
Why?
|
Female | 21 | 2024 | 392458 | 0.180 |
Why?
|
Synovial Membrane | 2 | 2014 | 532 | 0.180 |
Why?
|
Neoplasms, Experimental | 2 | 2004 | 1225 | 0.180 |
Why?
|
Metaphor | 1 | 2020 | 41 | 0.180 |
Why?
|
Immune Tolerance | 4 | 2013 | 2307 | 0.180 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2004 | 1782 | 0.180 |
Why?
|
Interleukin-4 | 1 | 2024 | 1154 | 0.170 |
Why?
|
rap GTP-Binding Proteins | 1 | 2019 | 24 | 0.170 |
Why?
|
Genetic Counseling | 1 | 2023 | 628 | 0.170 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 13630 | 0.160 |
Why?
|
Policy | 1 | 2023 | 506 | 0.160 |
Why?
|
Altruism | 1 | 2020 | 208 | 0.150 |
Why?
|
New York | 1 | 2020 | 875 | 0.150 |
Why?
|
Lymph Node Excision | 1 | 2024 | 1269 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 532 | 0.150 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3790 | 0.150 |
Why?
|
Fibronectins | 2 | 2019 | 724 | 0.150 |
Why?
|
Lung Neoplasms | 3 | 2018 | 13382 | 0.150 |
Why?
|
Adenoma, Pleomorphic | 1 | 2018 | 75 | 0.140 |
Why?
|
Virus Diseases | 1 | 2003 | 716 | 0.140 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 955 | 0.140 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3352 | 0.140 |
Why?
|
Male | 15 | 2024 | 360675 | 0.130 |
Why?
|
Solubility | 1 | 2018 | 1085 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1664 | 0.130 |
Why?
|
Cell Proliferation | 4 | 2015 | 10421 | 0.130 |
Why?
|
Animals | 20 | 2024 | 168083 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 1 | 2024 | 1158 | 0.120 |
Why?
|
Glycosylation | 1 | 2018 | 1095 | 0.120 |
Why?
|
Adult | 9 | 2024 | 221083 | 0.120 |
Why?
|
Mice | 15 | 2024 | 81324 | 0.120 |
Why?
|
Signal Transduction | 7 | 2020 | 23415 | 0.120 |
Why?
|
Receptors, Notch | 1 | 2019 | 743 | 0.120 |
Why?
|
Fibroblasts | 2 | 2014 | 4137 | 0.110 |
Why?
|
Guideline Adherence | 1 | 2024 | 2218 | 0.110 |
Why?
|
Movement | 1 | 2021 | 1476 | 0.110 |
Why?
|
Dopamine | 1 | 2020 | 1606 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 3803 | 0.110 |
Why?
|
Nephritis, Interstitial | 1 | 2014 | 155 | 0.110 |
Why?
|
Students | 1 | 2023 | 1737 | 0.100 |
Why?
|
Antigens, CD | 8 | 2008 | 4008 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2019 | 1012 | 0.100 |
Why?
|
Cell Adhesion | 1 | 2019 | 3090 | 0.100 |
Why?
|
Dendritic Cells | 3 | 2015 | 2726 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 407 | 0.100 |
Why?
|
Lysophospholipids | 1 | 2014 | 337 | 0.100 |
Why?
|
Antibodies, Monoclonal | 6 | 2017 | 9185 | 0.100 |
Why?
|
Protein Transport | 1 | 2018 | 1959 | 0.100 |
Why?
|
Membrane Glycoproteins | 6 | 2005 | 3696 | 0.100 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2723 | 0.100 |
Why?
|
Reoperation | 1 | 2022 | 4304 | 0.100 |
Why?
|
Antibodies | 2 | 2018 | 2415 | 0.090 |
Why?
|
Arthritis, Experimental | 1 | 2013 | 291 | 0.090 |
Why?
|
Cisplatin | 2 | 2015 | 1651 | 0.090 |
Why?
|
Liver | 2 | 2004 | 7513 | 0.090 |
Why?
|
Middle Aged | 7 | 2024 | 220835 | 0.090 |
Why?
|
Aged | 9 | 2024 | 169266 | 0.090 |
Why?
|
Motor Activity | 1 | 2020 | 2712 | 0.090 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2008 | 294 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1868 | 0.090 |
Why?
|
Blotting, Western | 1 | 2018 | 5033 | 0.090 |
Why?
|
Genetic Testing | 1 | 2023 | 3536 | 0.090 |
Why?
|
Wnt Proteins | 1 | 2014 | 719 | 0.090 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2010 | 49 | 0.090 |
Why?
|
Medical Oncology | 1 | 2022 | 2316 | 0.090 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3882 | 0.090 |
Why?
|
Curriculum | 1 | 2023 | 3739 | 0.080 |
Why?
|
Communication | 1 | 2024 | 3852 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2015 | 725 | 0.080 |
Why?
|
Pilot Projects | 1 | 2023 | 8639 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5300 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4013 | 0.080 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2010 | 152 | 0.080 |
Why?
|
Interleukin-12 | 1 | 2011 | 578 | 0.080 |
Why?
|
Acetylation | 1 | 2011 | 1050 | 0.080 |
Why?
|
Cytokines | 4 | 2014 | 7386 | 0.080 |
Why?
|
Immune System | 1 | 2013 | 792 | 0.080 |
Why?
|
Lectins, C-Type | 2 | 2008 | 585 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3092 | 0.070 |
Why?
|
NAD | 1 | 2011 | 611 | 0.070 |
Why?
|
B-Lymphocytes | 3 | 2013 | 4744 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5333 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3335 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3388 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2011 | 974 | 0.070 |
Why?
|
Lymphocyte Depletion | 1 | 2008 | 602 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 3 | 2014 | 3754 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2024 | 22157 | 0.060 |
Why?
|
Antigens, Differentiation | 3 | 2004 | 918 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2013 | 14393 | 0.060 |
Why?
|
Prognosis | 2 | 2024 | 29672 | 0.060 |
Why?
|
Protein Binding | 1 | 2018 | 9300 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2008 | 9518 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5070 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 1987 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39121 | 0.060 |
Why?
|
Lymphocyte Activation | 3 | 2004 | 5478 | 0.060 |
Why?
|
Transfection | 2 | 2002 | 5750 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 976 | 0.060 |
Why?
|
Salivary Glands | 1 | 2005 | 229 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2010 | 913 | 0.060 |
Why?
|
Autoantigens | 1 | 2008 | 887 | 0.060 |
Why?
|
Proteins | 3 | 2003 | 5993 | 0.060 |
Why?
|
Sjogren's Syndrome | 1 | 2005 | 237 | 0.060 |
Why?
|
Kupffer Cells | 1 | 2003 | 143 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2003 | 249 | 0.050 |
Why?
|
Clonal Anergy | 1 | 2003 | 169 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3094 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3216 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 2008 | 2802 | 0.050 |
Why?
|
Self Tolerance | 1 | 2002 | 123 | 0.050 |
Why?
|
Tumor Escape | 1 | 2004 | 371 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2002 | 623 | 0.050 |
Why?
|
Propaganda | 1 | 2020 | 7 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2003 | 393 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 2410 | 0.050 |
Why?
|
Lymphoid Tissue | 1 | 2002 | 444 | 0.050 |
Why?
|
Histones | 1 | 2011 | 2570 | 0.050 |
Why?
|
Prescriptions | 1 | 2023 | 386 | 0.050 |
Why?
|
Indocyanine Green | 1 | 2022 | 233 | 0.050 |
Why?
|
Insulin-Secreting Cells | 1 | 2008 | 897 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 897 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2013 | 22129 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2002 | 627 | 0.040 |
Why?
|
Rats, Long-Evans | 1 | 2020 | 381 | 0.040 |
Why?
|
Germinal Center | 1 | 2002 | 380 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2002 | 6198 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7034 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 383 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4853 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6123 | 0.040 |
Why?
|
Child | 2 | 2023 | 80134 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9566 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 913 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5662 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11856 | 0.030 |
Why?
|
Mice, Nude | 1 | 2002 | 3604 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2014 | 18926 | 0.030 |
Why?
|
Violence | 1 | 2022 | 935 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5781 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2002 | 963 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2004 | 2549 | 0.030 |
Why?
|
Propionates | 1 | 2014 | 181 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1116 | 0.030 |
Why?
|
Isoxazoles | 1 | 2014 | 233 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2004 | 2528 | 0.030 |
Why?
|
Cricetulus | 1 | 2014 | 812 | 0.030 |
Why?
|
CHO Cells | 1 | 2014 | 1379 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2015 | 563 | 0.020 |
Why?
|
Hemorrhage | 1 | 2023 | 3422 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2013 | 472 | 0.020 |
Why?
|
Models, Immunological | 1 | 2013 | 515 | 0.020 |
Why?
|
Osteoarthritis | 2 | 2013 | 1063 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4421 | 0.020 |
Why?
|
Cricetinae | 1 | 2014 | 2412 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2003 | 3026 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2003 | 4372 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3441 | 0.020 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2010 | 103 | 0.020 |
Why?
|
Fluorouracil | 1 | 2015 | 1642 | 0.020 |
Why?
|
Osteoclasts | 1 | 2013 | 711 | 0.020 |
Why?
|
Acute Disease | 2 | 2014 | 7240 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2224 | 0.020 |
Why?
|
Benzamides | 1 | 2014 | 1370 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4795 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10552 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 16947 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3001 | 0.020 |
Why?
|
Paclitaxel | 1 | 2015 | 1730 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4565 | 0.020 |
Why?
|
Spleen | 1 | 2013 | 2290 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1371 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2051 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7567 | 0.020 |
Why?
|
Actins | 1 | 2014 | 2046 | 0.020 |
Why?
|
Th17 Cells | 1 | 2013 | 794 | 0.020 |
Why?
|
Leukocytes | 1 | 2014 | 2024 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2816 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1334 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3409 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1885 | 0.020 |
Why?
|
Ligands | 2 | 2002 | 3266 | 0.020 |
Why?
|
Brain Mapping | 1 | 2020 | 6635 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6775 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5776 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2002 | 5145 | 0.010 |
Why?
|
Rats | 1 | 2020 | 23713 | 0.010 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2010 | 826 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2005 | 5870 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12727 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58946 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2008 | 1822 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2003 | 130 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3114 | 0.010 |
Why?
|
Perforin | 1 | 2003 | 166 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2003 | 216 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3594 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2008 | 1251 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5195 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8529 | 0.010 |
Why?
|
Epitopes | 1 | 2008 | 2503 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1348 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2004 | 900 | 0.010 |
Why?
|
Time Factors | 1 | 2002 | 39953 | 0.010 |
Why?
|
Child, Preschool | 1 | 2002 | 42217 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2892 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5775 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9478 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2003 | 1176 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2003 | 1891 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 74219 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7574 | 0.010 |
Why?
|
Down-Regulation | 1 | 2003 | 2915 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2692 | 0.010 |
Why?
|
Up-Regulation | 1 | 2004 | 4111 | 0.010 |
Why?
|
Lymphocytes | 1 | 2002 | 2603 | 0.010 |
Why?
|
Autoimmunity | 1 | 2002 | 1354 | 0.010 |
Why?
|
Adolescent | 1 | 2002 | 88271 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3666 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2002 | 2243 | 0.010 |
Why?
|